What Provention Bio, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Sessa Capital (Master), L.p. | 10% owner | Apr 27 | Tender Offer · U | −15,567,497 | — | — | 0 |
| Pisano Wayne | Director | Apr 27 | Tender Offer · U | −7,500 | — | — | 0 |
| Leon Francisco | Chief Scientific Officer | Apr 27 | Tender Offer · U | −1,000,000 | — | — | 0 |
| Leon Francisco | Chief Scientific Officer | Apr 27 | Tender Offer · U | −1,500,000 | — | — | 0 |
| Leon Francisco | Chief Scientific Officer | Apr 27 | Tender Offer · U | −73,000 | — | — | 0 |
| Ramos Eleanor | Chief Medical Officer | Apr 27 | Tender Offer · U | −70,000 | — | — | 0 |
| Catlin Avery W | Director | Apr 27 | Tender Offer · U | −10,000 | — | — | 0 |
| Catlin Avery W | Director | Apr 27 | Tender Offer · U | −10,000 | — | — | 0 |
| Palmer Ashleigh | Director and CEO | Apr 27 | Tender Offer · U | −2,570,050 | — | — | 0 |
| Sessa Capital (Master), L.p. | 10% owner | Apr 21 | Gift · G | −224,617 | — | — | 0 |
| Sessa Capital (Master), L.p. | 10% owner | Apr 20 | Gift · G | −202,314 | — | — | 224,617 |
| Sessa Capital (Master), L.p. | 10% owner | Apr 14 | Open-market sale · S | −2,190,549 | $24.32 | −$53.3M | 15,567,497 |
| Sessa Capital (Master), L.p. | 10% owner | Apr 14 | In/At-money Exercise · X | +8,879,023 | $6.00 | +$53.3M | 17,758,046 |
| Catlin Avery W | Director | Apr 13 | Gift · G | +10,000 | — | — | 10,000 |
| Catlin Avery W | Director | Apr 13 | Gift · G | −10,000 | — | — | 10,000 |
| Leon Francisco | Chief Scientific Officer | Apr 13 | Gift · G | +1,500,000 | — | — | 73,000 |
| Leon Francisco | Chief Scientific Officer | Apr 13 | Gift · G | −1,500,000 | — | — | 73,000 |
| Sessa Capital (Master), L.p. | 10% owner | Apr 04 | Gift · G | −218,651 | — | — | 426,931 |
| Sessa Capital (Master), L.p. | 10% owner | Mar 31 | Other Transaction · J | −3,000,000 | — | — | 8,879,023 |
| Palmer Ashleigh | Director and CEO | Feb 13 | Open-market sale · S | −25,835 | $10.04 | −$259K | 2,570,050 |
Loading...
